AzTrials
AzTrials

Osteoarticular InfectionsMOLOSNCT01193803

Molecular Microbiology in Osteo-arthritis Infection

An observational study of Osteoarticular Infections, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Osteoarticular Infections
What is being tested?
Microbiological cultures and Molecular biology
Type of treatment
Vaccines, Surgery or procedure
How many people
229 participants
Where
1 siteFrance
Study dates
Oct 2008to Jun 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection and control patients.

Who may be able to join

  • Patient are more than 18 years old
  • Patient who do not declined to have his medical records reviewed for research
  • Spondylodiscitis (S) group:
  • Patients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context. Spinal biopsies will be justified by one or more clinical or imaging findings:
  • Clinical presentation
  • Spinal pain unrelieved by rest
Show all 39Show fewer
  • Localized tenderness, Neurological deficits or limited range of motion
  • Fever > 38°C
  • Imaging findings (plain radiographs, MRI or CT):
  • Erosions of end plates on adjacent vertebral bodies
  • Decreased height of the intervertebral disk
  • Presence of a nonvascularized zone suggesting presence of pus or necroses in intervertebral, epidural space or in paraspinal soft-tissues
  • Prosthetic Joint Infection (PJI) Group
  • Patients suspected of Prosthetic Joint Infection were defined by the need of surgical revision for diagnostic or therapeutic aiming in infectious context. This revision will be justified by one or more clinical, biological or imaging findings:
  • Clinical presentation
  • Persistent joint pain
  • Fever > 38°C
  • Erythematous, swollen, fluctuant, and/or tender surgical wound
  • Wound dehiscence
  • Limited range of joint motion
  • Biological findings
  • CRP > 10 mg/l
  • Synovial leukocytes count > 1500/mm3 and polymorphonuclear leukocytes > 65%
  • Imaging findings
  • Prosthesis loosening: Periprosthetic osteolysis, progressive peri-prosthetic edging
  • Scintigraphy by means of a technetium (Tc99m) scan, gallium citrate (Ga67) scan, or indium (In111)-labeled leukocyte showing fixation around the prosthesis.
  • Septic arthritis (SA) Group
  • Patients suspected of Septic arthritis without prosthesis were defined by the need of synovial punction and/or biopsy justified by one or more clinical, biological or imaging findings:
  • Clinical presentation
  • Acute joint pain and/or swelling
  • Adenopathy near inflammatory joint
  • Fever > 38°CBiological findings
  • WBC > 10 000/ mm3
  • CRP > 10 mg/l
  • Synovial leukocytes count > 2000/mm3 or polymorphonuclear leukocytes > 90%
  • Imaging findings:
  • Capsular and surrounding soft-tissues swelling
  • Synovial notch and/or demineralization
  • Periarticular Abscess

Who cannot join

  • Patients already include.
  • Patient without health insurance
  • Antibiotic treatment before sampling does not constitute an exclusion criterion
  • Patient with one or more criteria:
  • Suspicion of concomitant infection defined by a fever >38°C and CRP > 10mg/l
  • Arthrosis treated by infiltration in the 6 months which preceding inclusion
  • Rapidly progressive arthrosis Prosthesis loosening or bone necrosis presumed to be aseptic
  • Patients with prior spinal instrumentation or surgery

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital LARIBOISIERE

    Paris, 75010

Other trials in France

About this study

Official title: Interest of Molecular Biology for Diagnostic of Osteo-arthritis Infections. EE Observational Prospective Study

Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. The rate of detection varies according to infection type: from 50 to 70% for infectious spondylodiscitis, 65 to 95% for prosthetic joint infections, 50% for gonococcal arthritis and 90% for non-gonococcal arthritis. The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular methods in case of osteoarticular infections. The gold standard will be established by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, an anatomy-pathologist and a rheumatologist), which established the final diagnosis of infected or not infected patients.

Read the detailed description

Background: Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria and it seems that the microbiological cultures are sufficient in most cases to establish the diagnosis. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. In addition, previous experimental data show that molecular methods could produce a diagnosis missing by conventional cultures. Main objective: The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular method by considering for the definition of cases an accumulation of clinical, radiological and biological arguments usually used to establish the diagnosis of bone and joint infections. The discordance of the two methods will be secondary classified by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, a anatomy-pathologist and a rheumatologist).Tested hypothesis:Interest of molecular methods for the diagnosis of osteoarticular infections.Secondary objective:Quantification of the delay of the results obtained by the two methods Study design: · One centre specialized in osteoarticular infections· Observational prospective study· Two methods of diagnosis: cultures and molecular methods· An expert group Included patients and number of patients: Total of 284 patients composed by 194 cases and 90 controlsIncluded patients (n=194) will all have a suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection defined by inclusions criteria.Results of the included patients will be compared to those obtained from the group of control patients (n=90).Protocol of duration: Study duration is 6 months for each patientThe protocol duration is planned for 2 yearsProcedures:All samples will be treated with the same procedure - Samples (synovial fluids, biopsies, ..) will be recovered either during surgery, by puncture aspiration at the bedside, or by guided ultrasonography, all under sterile conditions (mask, sterile gloves, cautious skin preparation and towelling) and transported to the Bacteriology department in sterile tubes without additional substrate in less than 12 hours. - Bacteriological procedures will be performed according to the guidelines applied for osteoarticular infection · Liquid samples: erythrocyte and leukocyte counts, polymorphonuclear percentage · Solid specimens: crushed using a mechanic apparatus · Gram and auramine staining· Cultures at 37°C on Columbia sheep blood agar (aerobically and anaerobically for 5 days), chocolate agar supplemented with IsoVitaleX (with 5% CO2 for 5 days), brain heart infusion broth (anaerobically for 15 days with subcultures done after 10 days on the same agar media, even if aspect was not cloudy).· Mycobacterial culture : Lowenstein-Jensen and COLETSOS media, MGIT incubated for 3 months.- Molecular procedures· DNA manipulations pre- and post-PCR: in separate rooms with separate pipetting devices to prevent contamination of samples with foreign DNA. · Equipment used in pre-PCR steps: DNA-free and UV-irradiated. · DNA extraction based on Boom's method: QIAGEN kit and EZ1 BioRobot · Broad-range 16S rRNA gene amplification · Amplicons: sequenced in both directions on an ABIPRISM 3100 analyser (Applied Bio systems, COURTABOEUF, France). · Cloning experiments for several sequences in one sample· Analysis of sequence: GenBank using the BLASTN program through the website of the National Centre of Biotechnology Information.· Internal control PCR: b-actin gene· Real time PCR: for the detection of mycobacteria and gonococcal arthritis- Potential implications: We could have chosen, like the majority of the studies published to date, to compare our molecular method with another method of diagnosis (culture, histology). However, there is not currently gold standard and the diagnosis of osteoarticular infections generally rests on an accumulation of arguments. The rule of the expert group is to determine, with less possible error, if each patient included will be "infected". This methodology is close to daily clinical reality and trusted in physician who was treating the patient. If the study shows an advantage of the molecular biology versus classical methods in our groups it would then be justified to discuss the diagnosis diagram of osteoarticular infections.

Being tested
Microbiological cultures and Molecular biology
Keywords
Prosthetic Joint Infections, Vertebral Osteomyelitis, Septic arthritis, Molecular methods
Medical subject headings
Arthritis, Infectious

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Microbiological cultures and Molecular biologyProcedure or surgery

    Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.

    Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.

Study groups in NCT01193803
Study groupRoleWhat they receive
Spondylodiscitis control groupPatients needing vertebral biopsy looking for tumoral etiology
Receives: Procedure: Microbiological cultures and Molecular biology
Prosthetic Joint Infection control groupPatients with primary prosthetic arthrosis surgery
Receives: Procedure: Microbiological cultures and Molecular biology
Septic arthritis control groupArthrosic patients needing evacuating articular punction with leucocytes infiltration less than 1000 /mm3
Receives: Procedure: Microbiological cultures and Molecular biology
Spondylodiscitis case groupPatients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context.
Receives: Procedure: Microbiological cultures and Molecular biology
Prosthetic Joint Infection case groupPatients suspected of Prosthetic Joint Infection defined by the need of surgical revision for diagnostic or therapeutic aiming in infectious context.
Receives: Procedure: Microbiological cultures and Molecular biology
Septic arthritis case groupPatients suspected of Septic arthritis without prosthesis were defined by the need of synovial punction and/or biopsy
Receives: Procedure: Microbiological cultures and Molecular biology

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prosthetic Joint Infections, Vertebral Osteomyelitis and Septic arthritis: Frequency of detection with classical bacteriological methods and molecular methods

    Measured: Day 0

Secondary outcomes (1)
  1. Time of returned results by one or the other of the techniques

    Measured: up to 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2010 (estimated)
  2. Study startOct 2008
  3. Primary completionDec 2011
  4. Study completionJun 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
229 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01193803
Sponsor's protocol ID
CRC076057
Other IDs
297-08
Acronym
MOLOS
Status last verified
May 2014
First submitted
1 Apr 2010
Last updated
2 Jun 2014
Results posted
No
Data monitoring committee
No

Publications

  • Fihman V, Hannouche D, Bousson V, Bardin T, Liote F, Raskine L, Riahi J, Sanson-Le Pors MJ, Bercot B. Improved diagnosis specificity in bone and joint infections using molecular techniques. J Infect. 2007 Dec;55(6):510-7. doi: 10.1016/j.jinf.2007.09.001. Epub 2007 Oct 29.

    PubMed 18029022

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoarticular Infections, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 39 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prosthetic Joint Infections, Vertebral Osteomyelitis and Septic arthritis: Frequency of detection with classical bacteriological methods and molecular methods (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01193803, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in